-transparent.png){kind=logo}
A new immunoglobulin (Ig) for intravenous use was given in high doses to 4 children with refractory idiopathic thrombocytopenic purpura (ITP) and 2 children with idiopathic aplastic anemia (IAA). Within 5-10 days after initiation of Ig therapy the platelets of the children with ITP rose to 300,000-650,000/mm3 and could be maintained at normal levels with one Ig infusion every 1-3 weeks. No reaction was observed in the 2 patients with IAA.
Related Publications
P Imbach, and
S Barandun, and
C Baumgartner, and
A Hirt, and
F Hofer, and
H P Wagner
May 1988,
The Journal of pediatrics,
P Imbach, and
S Barandun, and
C Baumgartner, and
A Hirt, and
F Hofer, and
H P Wagner
January 1988,
British medical journal (Clinical research ed.),
P Imbach, and
S Barandun, and
C Baumgartner, and
A Hirt, and
F Hofer, and
H P Wagner
April 1989,
Australian and New Zealand journal of medicine,
P Imbach, and
S Barandun, and
C Baumgartner, and
A Hirt, and
F Hofer, and
H P Wagner
October 1983,
The Journal of pediatrics,
P Imbach, and
S Barandun, and
C Baumgartner, and
A Hirt, and
F Hofer, and
H P Wagner
November 1987,
American journal of hematology,
P Imbach, and
S Barandun, and
C Baumgartner, and
A Hirt, and
F Hofer, and
H P Wagner
August 1981,
Lancet (London, England),
P Imbach, and
S Barandun, and
C Baumgartner, and
A Hirt, and
F Hofer, and
H P Wagner
January 1987,
European journal of pediatrics,
P Imbach, and
S Barandun, and
C Baumgartner, and
A Hirt, and
F Hofer, and
H P Wagner
January 1991,
Acta paediatrica Scandinavica,
P Imbach, and
S Barandun, and
C Baumgartner, and
A Hirt, and
F Hofer, and
H P Wagner
June 1985,
The Journal of pediatrics,
P Imbach, and
S Barandun, and
C Baumgartner, and
A Hirt, and
F Hofer, and
H P Wagner
January 1989,
Haematologica,
